|
🐜
|
Complications Related to the Endoscopic Endonasal Transsphenoidal Approach for Nonfunctioning Pituitary Macroadenomas in 300 Consecutive Patients.
10 auth.
E. Magro,
T. Graillon,
Jérome Lassave,
F. Castinetti,
S. Boissonneau,
E. Tabouret,
...
S. Fuentes,
L. Velly,
R. Gras,
H. Dufour
|
6 |
2016 |
6
🐜
|
|
🦁
|
Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial
22 auth.
T. Graillon,
M. Sanson,
C. Campello,
A. Idbaih,
M. Peyre,
H. Peyrière,
N. Basset,
D. Autran,
C. Roche,
M. Kalamarides,
...
P. Roche,
S. Fuentes,
E. Tabouret,
M. Barrié,
Anita Cohen,
S. Honoré,
M. Boucekine,
K. Baumstarck,
D. Figarella-Branger,
A. Barlier,
H. Dufour,
O. Chinot
|
6 |
2020 |
6
🦁
|
|
🐜
|
De novo and secondary anaplastic meningiomas: a study of clinical and histomolecular prognostic factors
12 auth.
M. Peyre,
G. Gauchotte,
M. Giry,
S. Froehlich,
J. Pallud,
T. Graillon,
...
F. Bielle,
D. Cazals‐Hatem,
P. Varlet,
D. Figarella-Branger,
H. Loiseau,
M. Kalamarides
|
6 |
2018 |
6
🐜
|
|
🐜
|
Activity of PD-1 blockade with Nivolumab among patients with recurrent atypical/anaplastic meningioma: Phase II trial results.
30 auth.
W. Bi,
L. Nayak,
David M. Meredith,
Joseph Driver,
Z. Du,
Samantha E. Hoffman,
Yvonne Y. Li,
E. Lee,
R. Beroukhim,
M. Rinne,
Ricardo McFaline-Figueroa,
U. Chukwueke,
Christine McCluskey,
Sarah C. Gaffey,
A. Cherniack,
...
J. Stefanik,
L. Doherty,
C. Taubert,
Meghan Cifrino,
D. Lafrankie,
T. Graillon,
P. Wen,
K. Ligon,
O. Al-Mefty,
Raymond Y Huang,
A. Muzikansky,
E. Chiocca,
S. Santagata,
I. Dunn,
D. Reardon
|
5 |
2021 |
5
🐜
|
|
🐬
|
Skull Base Chordomas and Chondrosarcomas
Natalia Kremenevski,
S. Schlaffer,
R. Coras,
T. Kinfe,
T. Graillon,
M. Buchfelder
|
5 |
2020 |
5
🐬
|
|
🐜
|
Recurrence of glioblastoma after radio-chemotherapy is associated with an angiogenic switch to the CXCL12-CXCR4 pathway
12 auth.
E. Tabouret,
A. Tchoghandjian,
E. Denicolai,
C. Delfino,
P. Metellus,
T. Graillon,
...
C. Boucard,
I. Nanni,
L. Padovani,
L. Ouafik,
D. Figarella-Branger,
O. Chinot
|
5 |
2015 |
5
🐜
|
|
🦁
|
Octreotide therapy in meningiomas: in vitro study, clinical correlation, and literature review.
11 auth.
T. Graillon,
D. Romano,
Céline Défilles,
A. Saveanu,
A. Mohamed,
D. Figarella-Branger,
...
P. Roche,
S. Fuentes,
O. Chinot,
H. Dufour,
A. Barlier
|
5 |
2017 |
5
🦁
|
|
🐜
|
Somatostatin Receptor–Targeted Radiopeptide Therapy in Treatment-Refractory Meningioma: Individual Patient Data Meta-analysis
20 auth.
C. Mirian,
A. Duun-Henriksen,
A. Maier,
M. M. Pedersen,
L. R. Jensen,
A. Bashir,
T. Graillon,
M. Hrachova,
D. Bota,
Martjin van Essen,
...
Petar-Marko Spanjol,
C. Kreis,
I. Law,
H. Broholm,
L. Poulsgaard,
K. Fugleholm,
Morten Ziebell,
T. Munch,
M. Walter,
T. Mathiesen
|
5 |
2020 |
5
🐜
|
|
🦁
|
Combined treatment by octreotide and everolimus: Octreotide enhances inhibitory effect of everolimus in aggressive meningiomas
14 auth.
T. Graillon,
Céline Défilles,
A. Mohamed,
Christophe Lisbonis,
A. Germanetti,
O. Chinot,
D. Figarella-Branger,
P. Roche,
T. Adetchessi,
S. Fuentes,
...
P. Metellus,
H. Dufour,
A. Enjalbert,
A. Barlier
|
5 |
2015 |
5
🦁
|
